SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dishman Pharma
Dishman Pharma
BSE: 532526NSE: DISHMANISIN: INE353G01020

17th-Jan-2012 08:52Source: BSE

Dishman Pharma - Acquisition of Creapharm Parenterals

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that Company's Wholly Owned Subsidiary company, namely Carbogen Amcis AG., Switzerland has acquired Creapharm Parenterals, a subsidiary of France based Greapharm Group.

Creapharm Parenterals is a contract development and manufacturing organization specializing in liquid, semi-solid and injectable aseptic dosage forms. As part of this acquisition, Creapharm Parenterals has changed its name to CARBOGEN AMCIS SAS.

The acquisition will extend CARBOGEN AMCIS' comprehensive range of development and manufacturing services by adding complementary formulation, lyophilization services and sterile GMP capabilities for the fast supply of drug products, including highly potents, for preclinical studies and clinical trials (Phase I, II & III).

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(October 22, 2014)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
3150

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1890

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1890

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.